Covered recipient · General Payments record
ANN MARIE WHITE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2023–2025
$751.57
- Reported across 35 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.29 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $38.31 | 2 |
| ABBVIE INC. | $31.60 | 1 |
| Otsuka America Pharmaceutical, Inc. | $30.43 | 1 |
| Verona Pharma, Inc. | $24.57 | 1 |
| Gilead Sciences, Inc. | $19.86 | 1 |
| Novo Nordisk AS | $18.05 | 1 |
| PFIZER INC. | $15.71 | 1 |
| ANI Pharmaceuticals, Inc. | $15.17 | 1 |
| Vanda Pharmaceuticals Inc. | $13.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.60 | 08/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204081967 | CMS |
| ANI Pharmaceuticals, Inc. | $15.17 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248626333 | CMS |
| Gilead Sciences, Inc. | $19.86 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234529857 | CMS |
| Lilly USA, LLC | $22.15 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186978830 | CMS |
| Lilly USA, LLC | $16.16 | 09/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186978832 | CMS |
| Novo Nordisk Inc | $18.05 | 07/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188925667 | CMS |
| Otsuka America Pharmaceutical, Inc. | $30.43 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228053319 | CMS |
| PFIZER INC. | $15.71 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229275360 | CMS |
| Vanda Pharmaceuticals Inc. | $13.59 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233144313 | CMS |
| Verona Pharma, Inc. | $24.57 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233803349 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.